Dr. Michael Cecchini, Associate Professor of Medicine at Yale School of Medicine, shares insights into the evolving landscape of gastrointestinal oncology. He discusses advancements in treating colorectal and rectal cancers, emphasizing the critical role of multidisciplinary coordination and early-phase clinical trials. Cecchini highlights how molecular profiling and next-generation systemic therapies are fundamentally changing patient treatment paradigms.
Cecchini, also Co-Director of the Colorectal Program at Yale's Center for Gastrointestinal Cancers, is a leading expert in gastrointestinal malignancies. His work includes serving as a Phase 1 Investigator at Yale Cancer Center and leading the GI Clinical Research Team.